| Breast cancer survivorship, quality of life, and late toxicities S Nardin, E Mora, FM Varughese, F D'Avanzo, AR Vachanaram, V Rossi, ... Frontiers in oncology 10, 864, 2020 | 182 | 2020 |
| Psychotropic drugs show anticancer activity by distrupting mitochondrial and lysosomal function M Varalda, A Antona, V Bettio, K Roy, AR Vachanaram, V Yellenki, ... Frontiers in Oncology 10, 2148, 2020 | 36 | 2020 |
| A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients … AM Mahmoud, F Biello, PM Maggiora, R Bruna, G Burrafato, M Cappelli, ... BMC geriatrics 21 (1), 320, 2021 | 6 | 2021 |
| 159P Peripheral T-lymphocytes senescence and response to neoadjuvant therapy (NAT) in operable breast cancer (BC) F D'Avanzo, V Rossi, C Saggia, F Platini, G Borra, V Martini, A Rua, ... Annals of Oncology 33, S611, 2022 | | 2022 |
| Abstract P2-07-06: Peripheral T-lymphocytes senescence and response to neoadjuvant therapy (NAT) in operable breast cancer (BC) V Martini, C Saggia, F D'Avanzo, V Rossi, I Dodaro, E Gallarotti, T Pretato, ... Cancer Research 82 (4_Supplement), P2-07-06-P2-07-06, 2022 | | 2022 |
| 1777P HEME catabolism in peripheral monocytes and response to immune checkpoint inhibitors in advanced lung cancer F Biello, V Martini, C Branni, G Borra, S Genestroni, A Mennitto, C Cattrini, ... Annals of Oncology 32, S1218, 2021 | | 2021 |
| PD-L1 status and efficacy of immune check-point inhibitors (ICIs) in advanced cancer patients: A pooled analysis of randomized trials. F Biello, DJ Pinato, G Borra, S Genestroni, G Siffredi, I Repetti, V Martini, ... Journal of Clinical Oncology 38 (15_suppl), e15263-e15263, 2020 | | 2020 |
